Medical Devices & Technology

DKOU 2026 Opens Registration, Targets Orthopedic Workforce Gap

Berlin – September 10, 2026 -- The German Congress for Orthopaedics and Trauma Surgery (DKOU) 2026 has published its full program and opened registration, with the four-day event set to run October 20-23, 2026 at CityCube Berlin.

DGOOC president frames congress as a hub for continuing education amid staff shortages

In a video interview released as part of a three-part series under the motto "Neue Wege gehen" (Taking New Paths), Dr. Jörn Dohle, president of the German Society for Orthopaedics and Orthopaedic Surgery (DGOOC), described DKOU as a "market of possibilities" combining specialized clinical content, interdisciplinary exchange and cross-sector dialogue. Dohle pointed to workforce shortages as a central challenge for the field, noting that while digital tools can support parts of patient care, recruiting young physicians and providing structured learning and exchange formats remains critical.

Sky Labs' CART Ring Hits 300,000 Prescriptions, Enters Korea BP Guidelines

Munich – September 10, 2026 -- Sky Labs presented new clinical data at ESC Congress 2026 showing its ring-shaped blood pressure monitor, CART, achieves an approximately 80% data-usability rate in continuous 24-hour monitoring of patients with atrial fibrillation, addressing a measurement gap left by traditional cuff-based devices in patients with irregular pulse or severe blood pressure fluctuations.

Chonnam University trial confirms 24-hour monitoring feasibility in atrial fibrillation patients

Professor Ki-Hong Lee of Chonnam National University Hospital reported that CART enabled precise observation of nocturnal blood pressure dipping patterns in atrial fibrillation patients, with a data-usability rate near 80% across continuous 24-hour recordings.

Sky Labs' CART Ring Validated for AFib, Heart Failure BP Monitoring

Munich – September 10, 2026 -- Sky Labs unveiled new clinical data at ESC Congress 2026 showing its ring-shaped blood pressure monitor CART achieved an 80% data evaluability rate in 24-hour monitoring of patients with atrial fibrillation (AFib), addressing a gap where conventional cuffs struggle with irregular pulses.

CART shows high concordance with standard ambulatory monitoring in severe heart failure patients

Professor In-Cheol Kim of Keimyung University Dongsan Hospital reported that CART, tested against conventional 24-hour ambulatory blood pressure monitoring (ABPM) in heart failure patients with a mean ejection fraction of 29%, showed high concordance and fully met European Society of Hypertension (ESH) error-margin criteria.

Sky Labs' CART Ring Shows 80% Data Accuracy in AFib, Heart Failure Trials

Munich – September 10, 2026 -- Sky Labs presented new clinical trial data for its ring-based blood pressure monitor, CART, at the ESC Congress 2026 in Munich on September 7, showing an 80% data evaluability rate in continuous monitoring of atrial fibrillation (AFib) patients and high correlation with standard ambulatory blood pressure monitoring (ABPM) in severe heart failure cases.

CART achieves 80% evaluability rate in 24-hour monitoring of atrial fibrillation patients

Professor Ki-Hong Lee of Chonnam National University Hospital reported that CART's ring-based 24-hour monitoring achieved approximately 80% data evaluability in AFib patients, enabling continuous tracking of nocturnal blood pressure dipping patterns that irregular pulse rates typically disrupt for cuff-based devices.

Orbis Flying Eye Hospital Debuts Simulation Training in Macau

Macau – September 09, 2026 -- Global eye care nonprofit Orbis International has launched its first-ever simulation-based training project in Macau, marking 20 years of local partnership that has raised more than US$33 million for the organization's work in China and worldwide.

Orbis brings 70 clinicians from eight Chinese hospitals for Flying Eye Hospital training

The project engages 70 ophthalmologists and nurses from eight Orbis partner hospitals across China, who will receive advanced training and mentorship aboard the Flying Eye Hospital aircraft and at Kiang Wu Nursing College of Macau. Training covers simulated cataract, glaucoma, strabismus, medical retina, and nursing specialties. Orbis states these professionals collectively serve more than 245,000 patients annually in China.

Anatomage Launches 3D-Printed Cadaver-Accurate Anatomy Models

Santa Clara – September 09, 2026 -- Anatomage Inc. has launched Anatomage Replica, a line of 3D printed physical anatomy models built from real cadaver data, targeting medical schools and clinical training programs seeking a cheaper alternative to plastinated human specimens.

Replica models translate Anatomage Table cadaver data into physical, reusable specimens

The models are derived from the Anatomage Table's real-human-based anatomy, which combines fully volumized digital bodies from real cadaver slices with highly accurate synthetic cadavers. Using 3D printing technology, the company converts this digital dataset into durable physical models that preserve the visual characteristics and anatomical relationships of the source cadavers.

Anatomage Launches 3D-Printed Cadaver-Based Anatomy Model Line

Santa Clara – September 09, 2026 -- Anatomage Inc. has launched Anatomage Replica, a line of 3D-printed physical anatomical models built from real cadaver data, giving medical educators a durable, reusable alternative to plastinated human specimens.

Anatomage Replica launches with five anatomical models derived from cadaver scans

The first Anatomage Replica set includes the heart, brain, hand, knee and foot, each featuring removable components that expose underlying structures for closer study. The models source their anatomical data from the Anatomage Table, the company's digital platform built on volumized scans of real cadavers and high-fidelity synthetic specimens.

Pulnovo's PADN Cuts Clinical Worsening Risk 51% in NEJM-Published Trial

Shanghai – September 09, 2026 -- Pulnovo Medical's pulmonary artery denervation (PADN) system reduced the risk of clinical worsening by 51% in patients with pulmonary hypertension linked to left heart disease (PH-LHD), according to results from the PADN-HF-PH trial presented at the European Society of Cardiology (ESC) Congress 2026 and simultaneously published in The New England Journal of Medicine.

Trial enrolled 264 patients across multiple centers under academician Yaling Han

The multicenter, randomized controlled study, led by academician Yaling Han of the General Hospital of Northern Theater Command, evaluated PADN as an add-on to guideline-directed medical therapy (GDMT) versus GDMT alone. Corresponding authors on the NEJM paper include Professor Shao-Liang Chen of Nanjing First Hospital and Professor Gregg W. Stone of Mount Sinai Hospital.

United Imaging Wins CE Mark for Dual Wide-Coverage CT Platform

Rotterdam – September 08, 2026 -- United Imaging has secured CE Mark certification for the uCT SiriuX and uCT SiriuX Ultrix, clearing what the company calls the world's first dual wide-coverage computed tomography family for commercial sale across Europe.

CE Mark Clears Twin-Ring Gantry System for European Sale

The certification covers a platform built on a Twin-Ring Gantry architecture, integrating dual-wide 16 cm Ultrix detectors with two liquid-metal-bearing X-ray tubes. The approval allows United Imaging to bring the systems into clinical use throughout the European market.

Texas Cardiac Arrhythmia Institute First US Site for New PFA Trial

Austin – September 08, 2026 -- The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center has become the first facility in the United States to enroll in a clinical trial evaluating a next-generation mapping and pulsed field ablation (PFA) system for patients with paroxysmal and persistent atrial fibrillation.

TCAI performs first procedure under global study leadership

Andrea Natale, M.D., executive medical director of TCAI and global principal investigator for the trial, conducted the first procedure using the new catheter system. The trial is designed to assess the safety and efficacy of the technology across both forms of atrial fibrillation, the most common cardiac arrhythmia, which affects millions of patients worldwide.